Abstract
Preparing for a clinical study on implant-enhance stroke rehabilitation Martin Schuettler, Chief Technology Officer at CorTec GmbH, addresses key questions around the development of the company’s innovative Brain Interchange System to support stroke rehabilitation therapy. CorTec has developed the Brain Interchange (BIC) implant system to improve stroke rehabilitation outcomes by enhancing the effect of conventional physio and/or occupational therapy. (1, 2) The effectiveness of the new implant-supported therapy will be investigated in an early feasibility study planned for 2024 to be carried out in Washington, US. While working on the approval of the feasibility study, uncertainties and unknowns of the study are investigated. These involve questions around usability and technical performance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.